|Articles|February 10, 2023
SCOPE 2023: Uniting Stakeholders With Patient Centricity
Author(s)Lisa Henderson
Len Rosenberg, head of clinical operations at Beat AML, comments on how his company not helps to advance the sector, but integrates new ways to conduct clinical trials.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Len Rosenberg, head of clinical operations at Beat AML, explains how the company's role as a neutral third party influences his ability to bring stakeholders together.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Ensuring Digital Trial Platforms Work for Underserved CommunitiesSeptember 10th 2025
How Sponsors Can Modernize Tools to Support PhysiciansSeptember 9th 2025
Using AI Trial-Matching Tools to Accelerate Patient AccessSeptember 8th 2025
Addressing the Digital Divide in Decentralized TrialsAugust 28th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Generative AI Transforms Clinical Study Report Development
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
